Defence Therapeutics Stock Price Patterns
| DTCFF Stock | USD 0.43 0.02 4.44% |
Momentum 43
Sell Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate trading signals. We use our internally-built news screening methodology to estimate the value of Defence Therapeutics based on different types of headlines from major news networks to social media. Using Defence Therapeutics hype-based prediction, you can estimate the value of Defence Therapeutics from the perspective of Defence Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Defence Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Defence Therapeutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Defence because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Defence Therapeutics after-hype prediction price | USD 0.43 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Defence |
Defence Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Defence Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Defence Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Defence Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Defence Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Defence Therapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Defence Therapeutics' historical news coverage. Defence Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 5.60, respectively. We have considered Defence Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Defence Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Defence Therapeutics is based on 3 months time horizon.
Defence Therapeutics OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Defence Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Defence Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Defence Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.41 | 5.17 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.43 | 0.43 | 0.00 |
|
Defence Therapeutics Hype Timeline
Defence Therapeutics is currently traded for 0.43. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Defence is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.41%. %. The volatility of related hype on Defence Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.43. The company recorded a loss per share of 0.15. Defence Therapeutics had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in a few days. Check out Defence Therapeutics Basic Forecasting Models to cross-verify your projections.Defence Therapeutics Related Hype Analysis
Having access to credible news sources related to Defence Therapeutics' direct competition is more important than ever and may enhance your ability to predict Defence Therapeutics' future price movements. Getting to know how Defence Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Defence Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PVCT | Provectus Biopharmaceuticals | 0.00 | 0 per month | 0.00 | (0.08) | 11.29 | (9.37) | 32.52 | |
| SEOVF | Sernova Corp | 0.00 | 0 per month | 4.32 | 0.02 | 10.00 | (9.09) | 28.33 | |
| MMIRF | MedMira | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 169.05 | |
| CYYNF | Cynata Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 25.00 | |
| MBXBF | Microbix Biosystems | 0.00 | 0 per month | 0.00 | (0.04) | 6.25 | (5.88) | 29.17 | |
| SPHRF | Starpharma Holdings Limited | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 45.54 | |
| CLYYF | Celyad Oncology SA | 0.00 | 0 per month | 0.00 | (0.20) | 0.00 | 0.00 | 16.67 | |
| BBIXF | Bonus BioGroup | 0.00 | 0 per month | 0.00 | 0.06 | 0.00 | 0.00 | 110.00 | |
| WOWU | WOWI Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FNCH | Finch Therapeutics Group | 0.00 | 0 per month | 1.55 | (0.02) | 3.21 | (3.44) | 8.64 |
Defence Therapeutics Additional Predictive Modules
Most predictive techniques to examine Defence price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Defence using various technical indicators. When you analyze Defence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Defence Therapeutics Predictive Indicators
The successful prediction of Defence Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Defence Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Defence Therapeutics based on analysis of Defence Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Defence Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Defence Therapeutics's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Defence OTC Stock analysis
When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges |